Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Engineered EVs designed to target diseases of the CNS.
Nieland L, Mahjoum S, Grandell E, Breyne K, Breakefield XO. Nieland L, et al. Among authors: breakefield xo. J Control Release. 2023 Apr;356:493-506. doi: 10.1016/j.jconrel.2023.03.009. Epub 2023 Mar 15. J Control Release. 2023. PMID: 36907561 Free PMC article. Review.
Heparin interferes with the uptake of liposomes in glioma.
van Solinge TS, Friis KP, O'Brien K, Verschoor RL, van Aarle J, Koekman A, Breakefield XO, Vader P, Schiffelers R, Broekman M. van Solinge TS, et al. Among authors: breakefield xo. Int J Pharm X. 2023 Jun 21;6:100191. doi: 10.1016/j.ijpx.2023.100191. eCollection 2023 Dec 15. Int J Pharm X. 2023. PMID: 37408568 Free PMC article.
Roles of extracellular vesicles in glioblastoma: foes, friends and informers.
Lunavat TR, Nieland L, Vrijmoet AB, Zargani-Piccardi A, Samaha Y, Breyne K, Breakefield XO. Lunavat TR, et al. Among authors: breakefield xo. Front Oncol. 2023 Nov 24;13:1291177. doi: 10.3389/fonc.2023.1291177. eCollection 2023. Front Oncol. 2023. PMID: 38074665 Free PMC article. Review.
Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients.
Yekula A, Hsia T, Kitchen RR, Chakrabortty SK, Yu W, Batool SM, Lewis B, Szeglowski AJ, Weissleder R, Lee H, Chi AS, Batchelor T, Carter BS, Breakefield XO, Skog J, Balaj L. Yekula A, et al. Among authors: breakefield xo. Neurooncol Adv. 2023 Sep 4;5(1):vdad104. doi: 10.1093/noajnl/vdad104. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37811539 Free PMC article.
Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.
Prabhakar S, Beauchamp RL, Cheah PS, Yoshinaga A, Abou Haidar E, Lule S, Mani G, Maalouf K, Stemmer-Rachamimov A, Jung DH, Welling DB, Giovannini M, Plotkin SR, Maguire CA, Ramesh V, Breakefield XO. Prabhakar S, et al. Among authors: breakefield xo. Mol Ther Methods Clin Dev. 2024 May 8;32(2):101262. doi: 10.1016/j.omtm.2024.101262. eCollection 2024 Jun 13. Mol Ther Methods Clin Dev. 2024. PMID: 38745896 Free PMC article.
Opportunities and challenges for innovative and equitable healthcare.
Ecker DJ, Aiello CD, Arron JR, Bennett CF, Bernard A, Breakefield XO, Broderick TJ, Callier SL, Canton B, Chen JS, Fishburn CS, Garrett B, Hecht SM, Janowitz T, Kliegman M, Krainer A, Louis CU, Lowe C, Sehgal A, Tozan Y, Tracey KJ, Urnov F, Wattendorf D, Williams TW, Zhao X, Hayden MR. Ecker DJ, et al. Among authors: breakefield xo. Nat Rev Drug Discov. 2024 May;23(5):321-322. doi: 10.1038/d41573-024-00032-4. Nat Rev Drug Discov. 2024. PMID: 38409339 No abstract available.
457 results